We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Global Hemostasis/Coagulation Analyzers Market to Reach USD 9.5 Billion by 2026

By LabMedica International staff writers
Posted on 01 Oct 2018
Print article
Image: The global hemostasis/coagulation analyzers market is expected to grow to USD 9.55 billion by 2026, driven mainly by the growing incidence of blood disorders (Photo courtesy of Analyticon Biotechnologies.
Image: The global hemostasis/coagulation analyzers market is expected to grow to USD 9.55 billion by 2026, driven mainly by the growing incidence of blood disorders (Photo courtesy of Analyticon Biotechnologies.
The global hemostasis/coagulation analyzers market was valued at USD 3.65 billion in 2017 and is expected to grow at a CAGR of 9.9% over the period 2018 to 2026 to reach USD 9.55 billion by 2026, driven mainly by the growing incidence of blood disorders. Technological innovations and miniaturization has led to the commercialization of several novel devices that have quick turnaround time and can also be used in point of care (POC) settings. Additionally, growing awareness and demand for technologically advanced medical treatments, government support and increasing adoption of laboratory automation are driving the demand for novel coagulation analyzers.

These are the latest findings of Research and Markets, (Dublin, Ireland), a global market research company.

Based on test types, the routine coagulation tests segment holds the largest share of the global hemostasis/coagulation analyzers market, due to a large number of these tests being performed for almost all surgical procedures and treatments. However, the diagnostic hemostasis assays segment is expected to register a faster growth rate due to the increasing adoption of specific tests such as VWF assays and thrombophilia testing, led by the growing awareness and prevalence of coagulation disorders. Based on product types, the devices (analyzers) segment holds a larger revenue share of the global hemostasis/coagulation analyzers market, driven by higher cost and continuously increasing purchase of these systems in the laboratory as well as POC settings. Based on end users, the diagnostic laboratories segment dominates the global hemostasis/coagulation analyzers market, led by greater preference for analyzing samples in specialized laboratories. Hemostasis analyzers have a high uptake in research institutions on account of the surge in the number of clinical trials being undertaken to commercialize novel drugs for the treatment of coagulation disorders.

Geographically, North America dominates the global hemostasis/coagulation analyzers market in terms of revenue, due to the presence of developed healthcare infrastructure, various R&D initiatives, and a high number of organ transplant and general surgeries performed in the region. However, the hemostasis/coagulation analyzers market in Asia Pacific is expected to witness the fastest growth, driven by growing awareness about hemostasis, increasing prevalence of diseases, both genetic and lifestyle linked, and rising healthcare expenditure due to the rapid evolution of healthcare infrastructure in the untapped markets of the region.

The hemostasis industry is characterized by the presence of several multinational players who have intensified their R&D efforts for the development of technologically advanced and more accurate analyzers. The major players are also undertaking penetration measures to enter the untapped markets in the Asia Pacific and Middle East & Africa.

Related Links:
Research and Markets

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Reagent Reservoirs
Reagent Reservoirs

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.